EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy
Status:
Not yet recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
This is a Platform Protocol to perform Phase II clinical trials in The Early Phase Pain
Investigation Clinical Network (EPPIC-Net), under The Helping to End Addiction Long-termSM
Initiative, or NIH HEAL InitiativeSM, related to the treatment of Painful Diabetic Peripheral
Neuropathy (PDPN) in a platform setting to test multiple assets under a single protocol.
Phase:
Phase 2
Details
Lead Sponsor:
James P. Rathmell, MD
Collaborators:
Icahn School of Medicine at Mount Sinai National Institute of Neurological Disorders and Stroke (NINDS) New York University